Transient high-level expression of ß-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA

GM1 gangliosidosis is an autosomal recessive disorder caused by the deficiency of lysosomal acid hydrolase ß-galactosidase (ß-Gal). It is one of the most frequent lysosomal storage disorders in Brazil, with an estimated frequency of 1:17,000. The enzyme is secreted and can be captured by deficient c...

Full description

Bibliographic Details
Main Authors: R.C. Balestrin, G. Baldo, M.B. Vieira, R. Sano, J.C. Coelho, R. Giugliani, U. Matte
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2008-04-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000400005
_version_ 1818510370118041600
author R.C. Balestrin
G. Baldo
M.B. Vieira
R. Sano
J.C. Coelho
R. Giugliani
U. Matte
author_facet R.C. Balestrin
G. Baldo
M.B. Vieira
R. Sano
J.C. Coelho
R. Giugliani
U. Matte
author_sort R.C. Balestrin
collection DOAJ
description GM1 gangliosidosis is an autosomal recessive disorder caused by the deficiency of lysosomal acid hydrolase ß-galactosidase (ß-Gal). It is one of the most frequent lysosomal storage disorders in Brazil, with an estimated frequency of 1:17,000. The enzyme is secreted and can be captured by deficient cells and targeted to the lysosomes. There is no effective treatment for GM1 gangliosidosis. To determine the efficiency of an expression vector for correcting the genetic defect of GM1 gangliosidosis, we tested transfer of the ß-Gal gene (Glb1) to fibroblasts in culture using liposomes. ß-Gal cDNA was cloned into the expression vectors pSCTOP and pREP9. Transfection was performed using 4 µL lipofectamine 2000 and 1.5-2.0 µg DNA. Cells (2 x 10(5)/well) were harvested 24 h, 48 h, and 7 days after transfection. Enzyme specific activity was measured in cell lysate and supernatant by fluorometric assay. Twenty-four hours after transfection, treated cells showed a higher enzyme specific activity (pREP9-ß-Gal: 621.5 ± 323.0, pSCTOP-ß-Gal: 714.5 ± 349.5, pREP9-ß-Gal + pSCTOP-ß-Gal: 1859.0 ± 182.4, and pREP9-ß-Gal + pTRACER: 979.5 ± 254.9 nmol·h-1·mg-1 protein) compared to untreated cells (18.0 ± 3.1 for cell and 32.2 ± 22.2 nmol·h-1·mg-1 protein for supernatant). However, cells maintained in culture for 7 days showed values similar to those of untreated patients. In the present study, we were able to transfect primary patients' skin fibroblasts in culture using a non-viral vector which overexpresses the ß-Gal gene for 24 h. This is the first attempt to correct fibroblasts from patients with GM1 gangliosidosis by gene therapy using a non-viral vector.
first_indexed 2024-12-10T22:58:18Z
format Article
id doaj.art-358f95a466a2477285cbd54efbaeb024
institution Directory Open Access Journal
issn 0100-879X
1414-431X
language English
last_indexed 2024-12-10T22:58:18Z
publishDate 2008-04-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-358f95a466a2477285cbd54efbaeb0242022-12-22T01:30:13ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2008-04-01414283288Transient high-level expression of ß-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNAR.C. BalestrinG. BaldoM.B. VieiraR. SanoJ.C. CoelhoR. GiuglianiU. MatteGM1 gangliosidosis is an autosomal recessive disorder caused by the deficiency of lysosomal acid hydrolase ß-galactosidase (ß-Gal). It is one of the most frequent lysosomal storage disorders in Brazil, with an estimated frequency of 1:17,000. The enzyme is secreted and can be captured by deficient cells and targeted to the lysosomes. There is no effective treatment for GM1 gangliosidosis. To determine the efficiency of an expression vector for correcting the genetic defect of GM1 gangliosidosis, we tested transfer of the ß-Gal gene (Glb1) to fibroblasts in culture using liposomes. ß-Gal cDNA was cloned into the expression vectors pSCTOP and pREP9. Transfection was performed using 4 µL lipofectamine 2000 and 1.5-2.0 µg DNA. Cells (2 x 10(5)/well) were harvested 24 h, 48 h, and 7 days after transfection. Enzyme specific activity was measured in cell lysate and supernatant by fluorometric assay. Twenty-four hours after transfection, treated cells showed a higher enzyme specific activity (pREP9-ß-Gal: 621.5 ± 323.0, pSCTOP-ß-Gal: 714.5 ± 349.5, pREP9-ß-Gal + pSCTOP-ß-Gal: 1859.0 ± 182.4, and pREP9-ß-Gal + pTRACER: 979.5 ± 254.9 nmol·h-1·mg-1 protein) compared to untreated cells (18.0 ± 3.1 for cell and 32.2 ± 22.2 nmol·h-1·mg-1 protein for supernatant). However, cells maintained in culture for 7 days showed values similar to those of untreated patients. In the present study, we were able to transfect primary patients' skin fibroblasts in culture using a non-viral vector which overexpresses the ß-Gal gene for 24 h. This is the first attempt to correct fibroblasts from patients with GM1 gangliosidosis by gene therapy using a non-viral vector.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000400005GM1 gangliosidosisß-galactosidase deficiencyGene therapyLysosomal storage disorderLipofectamine
spellingShingle R.C. Balestrin
G. Baldo
M.B. Vieira
R. Sano
J.C. Coelho
R. Giugliani
U. Matte
Transient high-level expression of ß-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA
Brazilian Journal of Medical and Biological Research
GM1 gangliosidosis
ß-galactosidase deficiency
Gene therapy
Lysosomal storage disorder
Lipofectamine
title Transient high-level expression of ß-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA
title_full Transient high-level expression of ß-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA
title_fullStr Transient high-level expression of ß-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA
title_full_unstemmed Transient high-level expression of ß-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA
title_short Transient high-level expression of ß-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA
title_sort transient high level expression of ss galactosidase after transfection of fibroblasts from gm1 gangliosidosis patients with plasmid dna
topic GM1 gangliosidosis
ß-galactosidase deficiency
Gene therapy
Lysosomal storage disorder
Lipofectamine
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000400005
work_keys_str_mv AT rcbalestrin transienthighlevelexpressionofßgalactosidaseaftertransfectionoffibroblastsfromgm1gangliosidosispatientswithplasmiddna
AT gbaldo transienthighlevelexpressionofßgalactosidaseaftertransfectionoffibroblastsfromgm1gangliosidosispatientswithplasmiddna
AT mbvieira transienthighlevelexpressionofßgalactosidaseaftertransfectionoffibroblastsfromgm1gangliosidosispatientswithplasmiddna
AT rsano transienthighlevelexpressionofßgalactosidaseaftertransfectionoffibroblastsfromgm1gangliosidosispatientswithplasmiddna
AT jccoelho transienthighlevelexpressionofßgalactosidaseaftertransfectionoffibroblastsfromgm1gangliosidosispatientswithplasmiddna
AT rgiugliani transienthighlevelexpressionofßgalactosidaseaftertransfectionoffibroblastsfromgm1gangliosidosispatientswithplasmiddna
AT umatte transienthighlevelexpressionofßgalactosidaseaftertransfectionoffibroblastsfromgm1gangliosidosispatientswithplasmiddna